Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-13 · accession 0001628280-26-019006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-13 | BMRN | Hardy Alexander | CEO, Dir | F - Tax | $58.51 | -2,941 | 156.4K | -2% | -$172.1K |
| D | 2026-03-17 | 2026-03-16 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $0.00 | +62.4K | 218.9K | +40% | $0 |
| D | 2026-03-17 | 2026-03-16 | BMRN | Hardy Alexander | CEO, Dir | A - Grant | $0.00 | +89.2K | 89.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-13 | F | D | 2,941 | $58.51 | 156,447 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-16 | A | A | 62,440 | $0.00 | 218,887 | D | — | — | (F1) Restricted stock units granted March 16, 2026. Price not applicable. |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2026-03-16 | A | A | 89,200 | $0.00 | 89,200 | D | $57.43 · 2027-03-16 to 2036-03-15 | 89,200 Common Stock | (F2) Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter. |